QUALITY OF LIFE OUTCOMES FOLLOWING ULTRASONIC DISSECTOR-ASSISTED VS. ELECTROCAUTERY DISSECTION IN MODIFIED RADICAL MASTECTOMY: PROSPECTIVE OBSERVATIONAL COHORT
Open Access
- 31 March 2025
- journal article
- Published by South Kazakhstan Medical Academy in Central Asian Journal of Medical Hypotheses and Ethics
- Vol. 6 (1) , 48-55
Abstract
Background: Breast cancer is one of the most common malignancies worldwide, with significant implications for patient quality of life (QoL). As survival rates improve, assessing the long-term effects of treatment has become crucial. Conventional electrocautery has been widely used for axillary lymph node dissection (ALND), but recent studies suggest that ultrasonic dissectors (ULDs) may offer advantages by reducing tissue trauma and postoperative complications. This study evaluates the impact of ALND using ULDs versus electrocautery on QoL in breast cancer patients. Methods: An observational study was conducted involving 73 female breast cancer patients (aged 18–80 years) undergoing modified radical mastectomy with ALND. Patients were divided into two groups: an intervention cohort (n=35) treated with the Söring Sonoca 300 ultrasonic dissector and a control cohort (n=38) treated with conventional electrocautery. QoL was assessed using the EORTC QLQ-C30 and QLQ-BR45 questionnaires at baseline, 3-, 6-, and 9-months post-treatment. Statistical analysis included chi-square tests for categorical variables and independent t-tests for continuous variables, with p<0.05 significancy. Results: At baseline, no significant differences were observed between the groups. However, at three months, the intervention group demonstrated significantly higher functional scores (66.3±8.2 vs. 59.0±6.7; p<0.001), lower symptom scores (41.7±4.0 vs. 46.3±5.6; p<0.001), and superior global health status (64.2±9.9 vs. 51.4±10.8; p<0.001). These improvements persisted at six months, with the intervention group maintaining better functional scores (76.2±10.2 vs. 57.5±7.3; p<0.001), lower symptom scores (37.9±7.8 vs. 44.9±9.6; p<0.001), and higher global health status (66.5±10.4 vs. 52.6±13.1; p<0.001). By nine months, the intervention group continued to exhibit superior outcomes: functional scale (79.5±11.1 vs. 64.8±9.9; p<0.001), symptom scale (38.3±7.8 vs. 45.4±7.0; p<0.001), and global health status (71.5±6.6 vs. 56.3±8.2; p<0.001). Conclusion: Reduced thermal damage and improved healing contribute to better functional outcomes and lower symptom burden. These findings support the integration of ULDs into surgical oncology practice to optimize patient recovery.Keywords
This publication has 15 references indexed in Scilit:
- Quality of Life Assessment Among Ethnically Diverse Black Prostate Cancer Survivors: A Constructivist Grounded Theory ApproachResearch Square, 2024
- “Post Mastectomy Pain Syndrome: A Systematic Review of Prevention Modalities”JPRAS Open, 2021
- An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45Annals of Oncology, 2020
- Patient reported outcome measures (PROMs) following mastectomy with breast reconstruction or without reconstruction: a systematic reviewGland Surgery, 2019
- The quality of life of Croatian women after mastectomy: a cross-sectional single-center studyBMC Public Health, 2018
- Neuropathic pain after breast cancer treatment and its impact on sleep quality one year after cancer diagnosisThe Breast, 2017
- A cross-sectional assessment of quality of life of breast cancer patients in Saudi ArabiaPublic Health, 2016
- A prospective study of quality of life in breast cancer patients undergoing radiation therapyAdvances in Radiation Oncology, 2016
- Assessing the impact of pain on the life of breast cancer survivors using the Brief Pain InventoryJournal of Physical Therapy Science, 2015
- Breast Cancer in Low and Middle Income Countries (LMICs): A Shifting Tide in Global HealthThe Breast Journal, 2014